Skip Navigation

Expanded Access Protocol EaP For Subjects Receiving Idecabtagene vicleucel That Is Nonconforming For commercial Release

Brief Summary

Type:
Multiple Myeloma

Study Type:
Treatment

Phase:
N/A

ClinicalTrials.gov Identifier:
NCT04771078

Study #:
STUDY00146514

Start Date:
Jun 13, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04771078

View Complete Trial Details & Eligibility at ClinicalTrials.gov